XML 73 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
COMMON STOCK AND STOCK PLANS
12 Months Ended
Dec. 28, 2014
COMMON STOCK AND STOCK PLANS  
COMMON STOCK AND STOCK PLANS

10.  COMMON STOCK AND STOCK PLANS

Common Stock

We have two classes of stock; Class A and Class B Common Stock. Both classes of stock participate equally in dividends. Holders of Class B are entitled to one vote per share and to elect as a class 75% of the Board of Directors, rounded down to the nearest whole number. Holders of Class A Common Stock are entitled to one-tenth of a vote per share and to elect as a class 25% of the Board of Directors, rounded up to the nearest whole number.

Class B Common Stock is convertible at the option of the holder into Class A Common Stock on a share‑for‑share basis. During fiscal year 2014, 215,000 Class B Common Shares were converted to Class A Common Shares at the request of a holder.

The holders of shares of Class B Common Stock are parties to an agreement, the intent of which is to preserve control of the Company by the McClatchy family. Under the terms of the agreement, the Class B shareholders have agreed to restrict the transfer of any shares of Class B Common Stock to one or more “Permitted Transferees,” subject to certain exceptions. A “Permitted Transferee” is any of our current holders of shares of Class B Common Stock; any lineal descendant of Charles K. McClatchy (1858 to 1936); or a trust for the exclusive benefit of, or in which all of the remainder beneficial interests are owned by, one or more lineal descendants of Charles K. McClatchy.

Generally, Class B shares can be converted into shares of Class A Common Stock and then transferred freely (unless, following conversion, the outstanding shares of Class B Common Stock would constitute less than 25% of the total number of all our outstanding shares of common stock). In the event that a Class B shareholder attempts to transfer any shares of Class B Common Stock in violation of the agreement, or upon the happening of certain other events enumerated in the agreement as “Option Events,” each of the remaining Class B shareholders has an option to purchase a percentage of the total number of shares of Class B Common Stock proposed to be transferred equal to such remaining Class B shareholder’s ownership percentage of the total number of outstanding shares of Class B Common Stock. If all the shares proposed to be transferred are not purchased by the remaining Class B shareholders, we have the option of purchasing the remaining shares. The agreement can be terminated by the vote of the holders of 80% of the outstanding shares of Class B Common Stock who are subject to the agreement. The agreement will terminate on September 17, 2047, unless terminated earlier in accordance with its terms.

Stock Plans

During fiscal year 2014, we had two stock‑based compensation plans, which are described below.

We have a stock incentive plan (the “2004 Plan”) that reserved 9,000,000 Class A Common shares for issuance to key employees and outside directors. The options vested in installments over four years, and once vested are exercisable up to 10 years from the date of grant. In addition, the 2004 Plan permitted the following type of incentive awards in addition to common stock, stock options and stock appreciation rights (“SARs”): restricted stock, unrestricted stock, stock units and dividend equivalent rights. The 2004 Plan was frozen in May 2012.

In May 2012 the shareholders approved The McClatchy Company 2012 Omnibus Incentive Plan (“2012 Plan”) to replace the 2004 Plan, for all future awards. The 2012 Plan provided that the Class A Common Stock available for issuance equal to 5,000,000 shares plus the number of shares available for future awards under the 2004 Plan as of the date of May 16, 2012 (the shareholder meeting date) plus the number of shares subject to awards outstanding under the 2004 Plan as of May 16, 2012, which terminate by expiration, forfeiture, cancellation or otherwise without the issuance of such shares. The 2012 Plan generally provides for granting of stock options or SARs only at an exercise price at least equal to fair market value on the grant date; a 10-year maximum term for stock options and SARs; no repricing of stock options or SARs without prior shareholder approval; and no reload or “evergreen” share replenishment features.

Stock Plans Activity

In fiscal year 2014, we granted 15,000 shares of Class A Common Stock to each non‑employee director, resulting in the issuance of 150,000 shares from the 2012 Plan. In fiscal year 2013, we granted 15,000 shares of Class A Common Stock to each non‑employee director, resulting in the issuance of 165,000 shares from the 2012 Plan.

We granted restricted stock units (“RSUs”) at fair market value on the date of grant to certain key employees from the 2012 Plan as summarized below. The RSUs generally vest three years after grant date but terms of each grant is at the discretion of the compensation committee of the board of directors.

The following table summarizes the RSUs stock activity:

 

 

 

 

 

 

 

 

 

    

 

    

Weighted

 

 

 

 

 

Average Grant

 

 

 

 

 

Date Fair

 

 

    

RSUs

    

Value

 

Nonvested — December 25, 2011

 

1,445,000 

 

$

3.73 

 

Granted

 

1,082,000 

 

$

2.59 

 

Vested

 

(765,000)

 

$

3.42 

 

Forfeited

 

(660,000)

 

$

3.48 

 

Nonvested — December 30, 2012

 

1,102,000 

 

$

2.98 

 

Granted

 

483,150 

 

$

2.46 

 

Vested

 

(320,000)

 

$

4.08 

 

Forfeited

 

(33,500)

 

$

2.48 

 

Nonvested — December 29, 2013

 

1,231,650 

 

$

2.50 

 

Granted

 

856,950 

 

$

4.61 

 

Vested

 

(717,150)

 

$

2.92 

 

Forfeited

 

(41,900)

 

$

2.93 

 

Nonvested — December 28, 2014

 

1,329,550 

 

$

3.62 

 

As of December 28, 2014, the total fair value of the RSUs that vested during the period was $3.4 million. As of December 28, 2014, there were $2.9 million of unrecognized compensation costs for nonvested RSUs, which are expected to be recognized over 2.0 years.

When SARs are granted they are granted at fair market value on the date of grant to certain key employees from the 2012 Plan. The SARs generally vest four years after grant date but terms of each grant is at the discretion of the compensation committee of the board of directors.

Outstanding options and SARs are summarized as follows:

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

Weighted

    

Aggregate

 

 

 

Options/

 

Average

 

Intrinsic Value

 

 

 

SARs

 

Exercise Price

 

(in thousands)

 

Outstanding December 25, 2011

 

6,723,250 

 

$

22.01 

 

$

874 

 

Granted

 

1,017,500 

 

$

2.76 

 

 

 

 

Exercised

 

(27,250)

 

$

1.70 

 

$

33 

 

Forfeited

 

(1,217,750)

 

$

54.52 

 

 

 

 

Expired

 

(301,250)

 

$

48.33 

 

 

 

 

Outstanding December 30, 2012

 

6,194,500 

 

$

11.45 

 

$

1,846 

 

Granted

 

775,000 

 

$

2.46 

 

 

 

 

Exercised

 

(545,750)

 

$

1.72 

 

$

847 

 

Forfeited

 

(58,500)

 

$

3.30 

 

 

 

 

Expired

 

(254,750)

 

$

48.97 

 

 

 

 

Outstanding December 29, 2013

 

6,110,500 

 

$

9.69 

 

$

2,384 

 

Granted

 

 —

 

$

 —

 

 

 

 

Exercised

 

(1,678,250)

 

$

2.86 

 

$

3,138 

 

Forfeited

 

(67,250)

 

$

3.38 

 

 

 

 

Expired

 

(516,250)

 

$

35.74 

 

 

 

 

Outstanding December 28, 2014

 

3,848,750 

 

$

9.28 

 

$

1,542 

 

Vested and Expected to Vest December 28, 2014

 

3,763,184 

 

$

9.43 

 

$

1,467 

 

Options exercisable:

 

 

 

 

 

 

 

 

 

December 30, 2012

 

3,826,250 

 

 

 

 

$

1,335 

 

December 29, 2013

 

3,983,875 

 

 

 

 

$

1,306 

 

December 28, 2014

 

2,719,750 

 

 

 

 

$

716 

 

As of December 28, 2014, there were $0.8 million of unrecognized compensation costs related to options and SARs granted under our plans. The cost is expected to be recognized over a weighted average period of 1.7 years.

The following tables summarize information about stock options and SARs outstanding in the stock plans at December 28, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

Average

    

 

 

    

 

    

 

 

 

 

 

 

 

Remaining

 

Weighted

 

 

 

Weighted

 

Range of Exercise

 

Options/SARs

 

Contractual

 

Average

 

Options/SARs

 

Average

 

Prices

 

Outstanding

 

Life

 

Exercise Price

 

Exercisable

 

Exercise Price

 

$1.70 – $9.07 

 

2,578,250 

 

6.17 

 

$

3.05 

 

1,449,250 

 

$

3.22 

 

$9.73 – $35.94 

 

951,000 

 

2.10 

 

$

13.19 

 

951,000 

 

$

13.19 

 

$40.95 – $73.36 

 

319,500 

 

1.57 

 

$

47.93 

 

319,500 

 

$

47.93 

 

Total

 

3,848,750 

 

4.78 

 

$

9.28 

 

2,719,750 

 

$

11.96 

 

The weighted average remaining contractual life of options exercisable at December 28, 2014, was 3.7 years. The weighted average remaining contractual life of options vested and expected to vest at December 28, 2014, was 4.7 years. The fair value of the stock options and SARs granted in fiscal years 2013 and 2012 were estimated on the date of grant using a Black‑Scholes option valuation model that used the assumptions noted in the following table. The expected life of the options represents the period of time that options granted were expected to be outstanding using the historical exercise behavior of employees. The expected dividend yield was based on historical dividends declared per year, giving consideration for any anticipated change and the estimated stock price over the expected life of the options based on historical experience. Expected volatility was based on historical volatility for a period equal to the stock option’s expected life for shares granted. The risk‑free rate for periods within the contractual life of the option was based on the U.S. Treasury yield curve in effect at the time of grant. We did not grant any SARs in fiscal year 2014.

 

 

 

 

 

 

 

 

 

 

    

2013

    

2012

 

Expected life in years

 

 

4.51 

 

 

6.52 

 

Dividend yield

 

 

NIL

 

 

NIL

 

Volatility

 

 

1.08 

 

 

0.9 

 

Risk-free interest rate

 

 

0.76 

%  

 

1.22 

%  

Weighted average exercise price of options/SARs granted

 

$

2.46 

 

$

2.76 

 

Weighted average fair value of options/SARs granted

 

$

1.85 

 

$

2.09 

 

Stock‑Based Compensation

Total stock‑based compensation expense consisted of the following:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Years Ended

 

 

 

December 28,

 

December 30,

 

December 30,

 

(in thousands)

 

2014

 

2013

 

2012

 

Stock-based compensation expense

    

$

3,479 

    

$

3,481 

    

$

3,517